InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: longfellow95 post# 201723

Sunday, 12/02/2018 5:43:25 PM

Sunday, December 02, 2018 5:43:25 PM

Post# of 709712
Longfellow95,

17 MAY 2012 Northwest Bio Provides Update On DCVax® -L Brain Cancer Trial.

Linda Powers, CEO of Northwest Bio, commented, “Of course, the evolution of this trial to a Phase III trial is no assurance of the outcome, and more than one Phase III trial can often be required for a product approval unless the clinical results are particularly strong. However, we are pleased to make this transition to Phase III, and believe that the package of amendments further enhances an already strong trial, positioning the Company to realize the potential of the DCVax®technology.”



https://nwbio.com/northwest-bio-provides-update-on-dcvax-l-brain-cancer-trial-2/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News